Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2024 Jan 18;43:21. doi: 10.1186/s13046-024-02953-9

Correction: Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

Wenyu Luo 1,2,3,4, Ti Wen 1,2,3,4,, Xiujuan Qu 1,2,3,4,
PMCID: PMC10795383  PMID: 38238826

Correction: J Exp Clin Cancer Res 43, 8 (2024)

10.1186/s13046-023-02935-3

Following publication of the original article [1], authors noticed an error in the Funding section. The correct funding should read as:

  • This work was supported by grants from Supporting the high-quality development of science and technology funding projects at China Medical University (To Xiujuan Qu, 2022JH2/20,200,039) (To Ti Wen, 2,023,020,792-JH2/202).

The correction does not affect the overall result or conclusion of the article. The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13046-023-02935-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Ti Wen, Email: wenti@cmu.edu.cn.

Xiujuan Qu, Email: xjqu@cmu.edu.cn.

References

  • 1.Luo W, Wen T, Qu X. Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. J Exp Clin Cancer Res. 2024;43:8. doi: 10.1186/s13046-023-02935-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES